Maralixibat for treating cholestatic pruritus in Alagille syndrome [ID3941]
In development
Reference number: GID-TA10832
Expected publication date: TBC
Following the committee discussion in November 2024, this appraisal was paused to allow the company and NHS England to enter into a commercial discussion. Further to ongoing discussions between the company, NHS England and NICE, the appraisal will now be paused for a further period to allow commercial discussions to continue. Once these discussions have concluded, NICE will update stakeholders with the next steps. We hope to provide a further update in February 2026.